Literature DB >> 16604824

Effects of selective brain cooling in patients with severe traumatic brain injury: a preliminary study.

W G Liu1, W S Qiu, Y Zhang, W M Wang, F Lu, X F Yang.   

Abstract

We prospectively investigated non-invasive selective brain cooling (SBC) in patients with severe traumatic brain injury. Sixty-six in-patients were randomized into three groups. In one group, brain temperature was maintained at 33 - 35 degrees C by cooling the head and neck (SBC); in a second group, mild systemic hypothermia (MSH; rectal temperature 33 - 35 degrees C) was produced with a cooling blanket; and a control group was not exposed to hypothermia. Natural rewarming began after 3 days. Mean intracranial pressure 24, 48 or 72 h after injury was significantly lower in the SBC group than in the control group. Mean serum superoxide dismutase levels on Days 3 and 7 after injury in the SBC and MSH groups were significantly higher than in the control group. The percentage of patients with a good neurological outcome 2 years after injury was 72.7%, 57.1% and 34.8% in the SBC, MSH and control groups, respectively. Complications were managed without severe sequelae. Non-invasive SBC was safe and effective.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16604824     DOI: 10.1177/147323000603400107

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  26 in total

1.  Treatment of resistant fever: new method of local cerebral cooling.

Authors:  Susanne Mink; Urs Schwarz; Regina Mudra; Christoph Gugl; Jürg Fröhlich; Emanuela Keller
Journal:  Neurocrit Care       Date:  2011-08       Impact factor: 3.210

Review 2.  Global neurotrauma research challenges and opportunities.

Authors:  Andrés M Rubiano; Nancy Carney; Randall Chesnut; Juan Carlos Puyana
Journal:  Nature       Date:  2015-11-19       Impact factor: 49.962

3.  Therapeutic Hypothermia Reduces Intracranial Pressure and Partial Brain Oxygen Tension in Patients with Severe Traumatic Brain Injury: Preliminary Data from the Eurotherm3235 Trial.

Authors:  Liam M C Flynn; Jonathan Rhodes; Peter J D Andrews
Journal:  Ther Hypothermia Temp Manag       Date:  2015-05-19       Impact factor: 1.286

4.  Brain hypothermia induced by cold spinal fluid using a torso cooling pad: theoretical analyses.

Authors:  Katisha D Smith; Liang Zhu
Journal:  Med Biol Eng Comput       Date:  2010-06-04       Impact factor: 2.602

5.  Emergency Neurological Life Support: Intracranial Hypertension and Herniation.

Authors:  Rhonda Cadena; Michael Shoykhet; Jonathan J Ratcliff
Journal:  Neurocrit Care       Date:  2017-09       Impact factor: 3.210

Review 6.  Emergency Neurological Life Support: Intracranial Hypertension and Herniation.

Authors:  Robert D Stevens; Michael Shoykhet; Rhonda Cadena
Journal:  Neurocrit Care       Date:  2015-12       Impact factor: 3.210

7.  Mild passive focal cooling prevents epileptic seizures after head injury in rats.

Authors:  Raimondo D'Ambrosio; Clifford L Eastman; Felix Darvas; Jason S Fender; Derek R Verley; Federico M Farin; Hui-Wen Wilkerson; Nancy R Temkin; John W Miller; Jeffrey Ojemann; Steven M Rothman; Matthew D Smyth
Journal:  Ann Neurol       Date:  2012-12-07       Impact factor: 10.422

8.  Management of bleeding following major trauma: an updated European guideline.

Authors:  Rolf Rossaint; Bertil Bouillon; Vladimir Cerny; Timothy J Coats; Jacques Duranteau; Enrique Fernández-Mondéjar; Beverley J Hunt; Radko Komadina; Giuseppe Nardi; Edmund Neugebauer; Yves Ozier; Louis Riddez; Arthur Schultz; Philip F Stahel; Jean-Louis Vincent; Donat R Spahn
Journal:  Crit Care       Date:  2010-04-06       Impact factor: 9.097

9.  A Head and Neck Support Device for Inducing Local Hypothermia.

Authors:  Adam Gladen; Paul A Iaizzo; John C Bischof; Arthur G Erdman; Afshin A Divani
Journal:  J Med Device       Date:  2013-12-06       Impact factor: 0.582

Review 10.  Head injury (moderate to severe).

Authors:  Ian Maconochie; Mark Ross
Journal:  BMJ Clin Evid       Date:  2007-10-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.